Targeting PD-1/PD-L1 in lung cancer: current perspectives

Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/PD-L1 antibodies are currently in advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Cao, María, Karachaliou, Niki, Viteri, Santiago, Morales-Espinosa, Daniela, Teixidó, Cristina, Sánchez Ruiz, Jesús, Molina-Vila, Miquel Ángel, Santarpia, Mariacarmela, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217517/
https://www.ncbi.nlm.nih.gov/pubmed/28210151
http://dx.doi.org/10.2147/LCTT.S55176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217517/
https://www.ncbi.nlm.nih.gov/pubmed/28210151
http://dx.doi.org/10.2147/LCTT.S55176

Ejemplares similares